You are here

AN EFFECTIVE ORAL MALE ANTIFERTILITY AGENT, WHICH IS BOTH NONTOXIC AND REVERSIBLE, IS NOT CURRENTLY AVAILABLE.

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 3125
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1985
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
763 Concord Avenue
Cambridge, MA 02138
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 HARRY G. PARS
 PRINCIPAL INVESTIGATOR
 (617) 354-2800
Business Contact
Phone: () -
Research Institution
N/A
Abstract

AN EFFECTIVE ORAL MALE ANTIFERTILITY AGENT, WHICH IS BOTH NONTOXIC AND REVERSIBLE, IS NOT CURRENTLY AVAILABLE. GOSSYPOL, THE MOST PROMISING NONSTEROIDAL MALE ANTIFERTILITY LEAD, HAS AN UNACCEPTABLY NARROW THERAPEUTIC RATIO. WE PROPOSE THAT THE THERAPEUTIC RATIO MAY BE IMPROVED BY ALTERATION OF THE PHARMACOKINETICS AND BIOAVAILABILITY THROUGH WATER-SOLUBILIZATION. ACCORDINGLY, SEVERAL CAREFULLY CHOSEN WATER-SOLUBLE DERIVATIVES OF GOSSYPOL WILL BE PREPARED. THESE COMPOUNDS WILL THEN BE TESTED FOR BOTH IN VITRO SPERMICIDAL ACTIVITY AND IN VIVO ANTIFERTILITY ACTIVITY. THE IN VIVO TESTS WILL BE EVALUATED BOTH IN TERMS OF EFFICACY AND TOXICITY. THE IDENTIFICATION OF A COMPOUND WITH THE SAME EFFICACY AS GOSSYPOL BUT WITHOUT THE TOXIC EFFECTS WOULD PROVIDE THE BASIS FOR FURTHER STUDY LEADING TO THE EVENTUAL

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government